MSC Industrial Direct, Radius Recycling And 3 Stocks To Watch Heading Into Tuesday
Portfolio Pulse from Avi Kapoor
U.S. stock futures are trading lower this morning. Key stocks to watch include MSC Industrial Direct (MSM), Y-mAbs Therapeutics (YMAB), Radius Recycling (RDUS), Fly-E Group (FLYE), and Simulations Plus (SLP). MSC Industrial Direct is expected to report earnings of $1.50 per share on $1.01 million revenue. Y-mAbs Therapeutics appointed a new CFO. Radius Recycling is expected to post a quarterly loss. Fly-E Group reported increased earnings and revenue. Simulations Plus is expected to post earnings of $0.15 per share on $17.96 million revenue.

July 02, 2024 | 6:29 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
MSC Industrial Direct is expected to report quarterly earnings of $1.50 per share on revenue of $1.01 million. Shares gained 1.1% in after-hours trading.
Positive earnings expectations and after-hours price increase suggest a likely short-term upward movement in MSM stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Radius Recycling is expected to post a quarterly loss of $0.66 per share on revenue of $693.90 million. Shares gained 4.6% in after-hours trading.
Despite expected losses, the significant after-hours price increase suggests positive investor sentiment, likely leading to short-term gains.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Simulations Plus is expected to post quarterly earnings of $0.15 per share on revenue of $17.96 million. Shares gained 0.7% in after-hours trading.
Positive earnings expectations and a slight increase in after-hours trading suggest a likely short-term upward movement in SLP stock.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Fly-E Group reported FY24 earnings of $0.9 per share, up from $0.6 per share in the previous year. Revenue rose to $32.2 million from $21.8 million. Shares fell 0.9% in after-hours trading.
Despite positive earnings and revenue growth, the decline in share price suggests negative short-term sentiment.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Y-mAbs Therapeutics named Peter Pfreundschuh as Chief Financial Officer, effective June 28. Shares fell 2.3% in after-hours trading.
The appointment of a new CFO led to a decline in share price, indicating potential short-term negative sentiment.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100